Skip to main content
Journal cover image

Skin Microbiome Variation with Cancer Progression in Human Cutaneous Squamous Cell Carcinoma.

Publication ,  Journal Article
Voigt, AY; Emiola, A; Johnson, JS; Fleming, ES; Nguyen, H; Zhou, W; Tsai, KY; Fink, C; Oh, J
Published in: J Invest Dermatol
October 2022

The skin microbiome plays a critical role in skin homeostasis and disorders. UVR is the major cause of nonmelanoma skin cancer, but other risk factors, including immune suppression, chronic inflammation, and antibiotic usage, suggest the microbiome as an additional, unexplored risk factor and potential disease biomarker. The overarching goal was to study the skin microbiome in squamous cell carcinoma (SCC) and premalignant actinic keratosis compared with that in healthy skin to identify skin cancer‒associated changes in the skin microbiome. We performed a high-resolution analysis of shotgun metagenomes of actinic keratosis and SCC in healthy skin, revealing the microbial community shifts specific to actinic keratosis and SCC. Most prominently, the relative abundance of pathobiont Staphylococcus aureus was increased at the expense of commensal Cutibacterium acnes in SCC compared with that in healthy skin, and enrichment of functional pathways in SCC reflected this shift. Notably, C. acnes associated with lesional versus healthy skin differed at the strain level, suggesting the specific functional changes associated with its depletion in SCC. Our study revealed a transitional microbial dysbiosis from healthy skin to actinic keratosis to SCC, supporting further investigation of the skin microbiome for use as a biomarker and providing hypotheses for studies investigating how these microbes might influence skin cancer progression.

Duke Scholars

Published In

J Invest Dermatol

DOI

EISSN

1523-1747

Publication Date

October 2022

Volume

142

Issue

10

Start / End Page

2773 / 2782.e16

Location

United States

Related Subject Headings

  • Skin Neoplasms
  • Microbiota
  • Keratosis, Actinic
  • Humans
  • Dermatology & Venereal Diseases
  • Carcinoma, Squamous Cell
  • Anti-Bacterial Agents
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Voigt, A. Y., Emiola, A., Johnson, J. S., Fleming, E. S., Nguyen, H., Zhou, W., … Oh, J. (2022). Skin Microbiome Variation with Cancer Progression in Human Cutaneous Squamous Cell Carcinoma. J Invest Dermatol, 142(10), 2773-2782.e16. https://doi.org/10.1016/j.jid.2022.03.017
Voigt, Anita Y., Akintunde Emiola, Jethro S. Johnson, Elizabeth S. Fleming, Hoan Nguyen, Wei Zhou, Kenneth Y. Tsai, Christine Fink, and Julia Oh. “Skin Microbiome Variation with Cancer Progression in Human Cutaneous Squamous Cell Carcinoma.J Invest Dermatol 142, no. 10 (October 2022): 2773-2782.e16. https://doi.org/10.1016/j.jid.2022.03.017.
Voigt AY, Emiola A, Johnson JS, Fleming ES, Nguyen H, Zhou W, et al. Skin Microbiome Variation with Cancer Progression in Human Cutaneous Squamous Cell Carcinoma. J Invest Dermatol. 2022 Oct;142(10):2773-2782.e16.
Voigt, Anita Y., et al. “Skin Microbiome Variation with Cancer Progression in Human Cutaneous Squamous Cell Carcinoma.J Invest Dermatol, vol. 142, no. 10, Oct. 2022, pp. 2773-2782.e16. Pubmed, doi:10.1016/j.jid.2022.03.017.
Voigt AY, Emiola A, Johnson JS, Fleming ES, Nguyen H, Zhou W, Tsai KY, Fink C, Oh J. Skin Microbiome Variation with Cancer Progression in Human Cutaneous Squamous Cell Carcinoma. J Invest Dermatol. 2022 Oct;142(10):2773-2782.e16.
Journal cover image

Published In

J Invest Dermatol

DOI

EISSN

1523-1747

Publication Date

October 2022

Volume

142

Issue

10

Start / End Page

2773 / 2782.e16

Location

United States

Related Subject Headings

  • Skin Neoplasms
  • Microbiota
  • Keratosis, Actinic
  • Humans
  • Dermatology & Venereal Diseases
  • Carcinoma, Squamous Cell
  • Anti-Bacterial Agents
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences